Kaya Holdings Inc., which became one of the first publicly traded companies to hold a cannabis license when it began operation in Portland, Oregon in 2014, recently announced that it has been approved to hold a license for therapeutic psilocybin.
The announcement came on May 7, stating that Kaya Holdings officially owns a Psilocybin Service Center license from the Oregon Health Authority. The business will be called The Sacred Mushroom, which is set to be a “full-service psychedelic treatment center that will allow clients to receive Psilocybin Treatments in a setting offering significant experience differentiators and concept innovations.” It also boasted that the business will be up and running “within the next 30 days,” which would be sometime around the first week of June.
The Sacred Mushroom is located atop a building in downtown Portland and contains 11,000 square feet. The idea behind the layout is a spacious “room to roam” design, with “unsurpassed comfort, optional private rooms, activity zones with yoga, listening stations, journaling chairs and art expression, a special “sensation room,” a relaxing indoor garden and customized experience through our proprietary Synergy By Design ‘your setting, your way’ program.”
The press release cited data from Precedence Research, which stated that the U.S. behavioral health market was valued at $83 million in 2022, and projected a value increase to $136 billion by 2032.
Kaya Holdings Inc.’s OTCBQ market symbol is KAYS, and the company currently holds three cannabis licenses in total: one in Portland, Oregon, and two in Greece.
According to KAYS CEO Craig Frank, psilocybin is the next frontier in psychedelic medicines. “The introduction of legal psilocybin treatments in Oregon marks the beginning of perhaps the most disruptive force in the mental health sector, transforming treatment protocol and redirecting resources,” Frank said in a press release. “Our distinctive guest experience model, the environment offered …
Read More
Author: Nicole Potter / High Times
